ArticleLung India : official organ of Indian Chest Society2026
Predictive value of baseline serum angiotensin-converting enzyme (sACE) levels for steroid response in sarcoidosis.
Article in Lung India : official organ of Indian Chest Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveSarcoidosis is a systemic granulomatous disease that primarily affects the lungs. Corticosteroids are the first-line therapy, but steroid resistance remains a major clinical challenge. This study evaluates baseline serum angiotensin-converting enzyme (sACE) levels as a potential biomarker for predicting steroid resistance in sarcoidosis.
methodsIn this prospective single-centre study, 188 patients with biopsy-confirmed sarcoidosis had baseline sACE levels measured before corticosteroid initiation using the Kasahara colorimetric technique. Associations between sACE levels and treatment response were analysed using logistic regression and ROC analysis (SPSS v21; significance at P < 0.05).
resultsThe mean age of the cohort was 54 years, with 62% women. Common symptoms included cough, dyspnoea, fatigue, and arthralgia; hypercalcemia was seen in 11%. Elevated baseline sACE > 64 U/L was found in 41% of cases. ROC analysis yielded an (AUC) of 0.788 (95% CI: 0.685-0.891), with 83% sensitivity and 73% specificity for predicting steroid resistance. On multi-variate analysis, elevated sACE (P < 0.001), age > 54 years (P < 0.001), fatigue (P = 0.002), hypercalcemia (P = 0.019), and mediastinal lymph node involvement on CECT (P = 0.036) were independent predictors of poor steroid response.
conclusionElevated baseline sACE levels show potential as an adjunctive biomarker for identifying patients at risk of steroid resistance in sarcoidosis. However, given its moderate specificity and absence of longitudinal validation, sACE should be interpreted cautiously and in conjunction with clinical and radiological parameters. Multi-centre studies with longer follow-up are warranted to confirm these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.